Common dysregulations of the CDK4/6-retinoblastoma protein (Rb) axis, like copy-number variation or overexpression as well as loss of negative regulators of the pathway, can lead to cancer formation (Sherr et al., 2016). Here, CDK4 is linked to cancer.